Professor Barry Gidal, a nationally recognized leader in epilepsy research, is driving progress in treatment and patient advocacy.
epilepsy
Non-Prescription CBD Product Labeling Largely Inaccurate, Study Finds
PharmD student Owen Miller leads an analysis finding that just 15 percent of CBD-infused oil, beverages, and other products are labeled correctly.
Education Empowers Epilepsy Patients
A patient education-focused research project led by Professor Barry Gidal and Assistant Professor Amanda Margolis explores how information can increase epilepsy medication adherence.